Review ArticleOpen Access

The CDC Denies Magnetic Elements in COVID Injectables While DARPA Promotes Mind-Control Research with Magnetic Nanoparticles Migrated to the Brain

··
DOI: 10.23958/ijirms/vol10-i07/2101· Pages: 255 - 271· Vol. 10, No. 07, (2025)· Published: July 7, 2025
PDF
Views: 3,604 PDF downloads: 500

Abstract

The CDC denies that COVID-19 injections from Pfizer, Moderna, or Novavax can cause magnetism, even at the site of the injection. The CDC claims that the three ferromagnetic metals consisting of iron, cobalt, and nickel, and the rare earth chemicals used in magnets cerium, hafnium, lanthanum, gadolinium, and erbium are not in the US approved injectables. However, a 2024 study using inductively coupled plasma-mass spectrometry (ICP-MS), detected all these and many other undeclared elements in lots of Pfizer, Moderna, and five other brands of COVID-19 injectables. By contrast with the CDC denials, James Giordano, who has become Director of the Defense Advanced Research Projects Agency (DARPA), has argued since 2018 that the human brain is the battleground for DARPA’s “disruptive technologies” of warfare using magnetic nanoparticles delivered “intranasally, intravenously, or intraorally” all without surgery to achieve “mind-control” by adjusting the frequencies, power, and directionality of the electromagnetic forces. The science of magnetofection is little known but has been under development for decades. We explain it here and ask, could militarized experimentation with magnetic nanoparticles be involved in causing the documented outcomes of proteinaceous clotting, cardio-vascular conditions, strokes, new autoimmune diseases, unprecedented rapidly developing “prion diseases”, “turbo” cancers, and sudden deaths many of these occurring in otherwise young and healthy recipients of the experimental COVID-19 injectables? The research discussed in this paper implies that an affirmative answer cannot be ruled out.

Keywords

biodefense researchbiosemiotic depth hypothesisiatrogenic magnetismmagnetofectionprion diseasesproteinaceous clotsstrokesudden unexpected deathturbo cancer

References

  1. J. W. Oller and C. A. Shaw, “From superficial damage to invasion of the nucleosome: ranking of morbidities by the biosemiotic depth hypothesis,” International Journal of Sciences, vol. 8, no. 06, pp. 51–73, Jun. 2019, https://doi.org/10.18483/ijSci.2069.DOI ↗Google Scholar ↗
  2. D. Santiago and J. W. Oller, “Abnormal clots and all-cause mortality during the pandemic experiment: five doses of COVID-19 vaccine are evidently lethal to nearly all Medicare participants,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 1, pp. 847–890, Apr. 2023, https://doi.org/10.56098/ijvtpr.v3i1.73.DOI ↗Google Scholar ↗
  3. K. D. Nance and J. L. Meier, “Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines,” ACS Cent. Sci., vol. 7, no. 5, pp. 748–756, May 2021, https://doi.org/10.1021/acscentsci.1c00197.DOI ↗Google Scholar ↗
  4. M. C. Roco and W. S. Bainbridge, “Converging Technologies for Improving Human Performance Nanotechnology , Biotechnology , Information Technology, and Cognitive Science.” National Science Foundation/Documents Report, 2002. Accessed: Jun. 27, 2025. [Online]. Available: https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/bioecon-%28%23%20023SUPP%29%20NSF-NBIC.pdfGoogle Scholar ↗
  5. C. Lee, B.-H. Koo, C.-B. Chae, and R. Schober, “The Internet of bio-nano things in blood vessels: System design and prototypes,” Journal of Communications and Networks, vol. 25, no. 2, pp. 222–231, Apr. 2023, https://doi.org/10.23919/JCN.2023.000001.DOI ↗Google Scholar ↗
  6. I. Akyildiz, M. Pierobon, S. Balasubramaniam, and Y. Koucheryavy, “The internet of Bio-Nano things,” IEEE Communications Magazine, vol. 53, p. 32, Apr. 2015, https://doi.org/10.1109/MCOM.2015.7060516.DOI ↗Google Scholar ↗
  7. J. Giordano, “The Brain as the Battlefield of the Future: Modern War Speaker Institute Series at the US Military Academy at West Point.” Accessed: May 03, 2025. [Online]. Available: https://www.google.com/search?client=firefox-b-1-d&channel=entpr&q=James+Giordano%2C+N%23#fpstate=ive&vld=cid:17be7141,vid:N02SK9yd60s,st:0Google Scholar ↗
  8. J. Giordano, The Battle for Your Mind: Neuroscience, Technology/AI & the OODA Loop w/ James Giordano, PhD | Flow, (Aug. 01, 2023). Accessed: May 02, 2025. [Online Video]. Available: https://www.youtube.com/watch?v=1cPWJfjXu7MGoogle Scholar ↗
  9. J. Giordano, “DARPA’s N3: The Future of Non-Surgical Brain Interfaces,” Institute for Biodefense Research. Accessed: Apr. 11, 2025. [Online]. Available: https://biodefenseresearch.org/darpas-n3-the-future-of-non-surgical-brain-interfaces/Google Scholar ↗
  10. J. Giordano and Defense Media Activity, “James Giordano,” Institute for National Strategic Studies. Accessed: May 28, 2025. [Online]. Available: https://inss.ndu.edu/Media/Biographies/Article-View/Article/4044640/james-giordano/https%3A%2F%2Finss.ndu.edu%2FMedia%2FBiographies%2FArticle-View%2FArticle%2F4044640%2Fjames-giordano%2FGoogle Scholar ↗
  11. J. A. Thorp, K. E. Thorp, E. K. Lile, and J. Viglione, “Unexpected magnetic attraction: Evidence for an organized energy field in the human body,” TheGMS, vol. 2, no. 4, pp. 1–15, Jul. 2021, https://doi.org/10.46766/thegms.pubheal.21071202.DOI ↗Google Scholar ↗
  12. T. Tuuminen, P. J. Suominen, and M. Ahonen, “Clinical manifestations of iatrogenic magnetism in subjects after receiving COVID-19 injectables: case report series,” International Journal of Innovative Research in Medical Science, vol. 10, no. 06, pp. 207–210, Jun. 2025, doi: 10.23958/ijirms/vol10-i06/2081.DOI ↗Google Scholar ↗
  13. L. Diblasi, M. Monteverde, D. Nonis, and M. Sangorrín, “At Least 55 Undeclared Chemical Elements Found in COVID-19 Vaccines from AstraZeneca, CanSino, Moderna, Pfizer, Sinopharm and Sputnik V, with Precise ICP-MS,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1367–1393, Oct. 2024, doi: 10.56098/mt1njj52.DOI ↗Google Scholar ↗
  14. A. S. Ulrich, “No Nanobots in Vaccines Just Lipids on the Loose: Commentary on Lee and Broudy (2024), ‘Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructs in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitundinal Study,’” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, p. 1244.1-1244.10, Sep. 2024, https://doi.org/10.56098/7hsjff81.DOI ↗Google Scholar ↗
  15. R. M. Davidson, D. Broudy, S. Yanowitz, D. Santiago, and J. John W. Oller, “True or False? At Least 55 Undeclared Chemical Elements Have Been Detected by ICP-MS in COVID-19 ‘Vaccines,’” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, Art. no. 2, Dec. 2024, https://doi.org/10.56098/98sw8e86.DOI ↗Google Scholar ↗
  16. D. Speicher, J. Rose, L. Gutschi, D. Wiseman, and K. McKernan, DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events. 2023. [Online]. Available: https://www.researchgate.net/publication/374870815_Speicher_DJ_et_al_DNA_fragments_detected_in_COVID-19_vaccines_in_Canada_DNA_fragments_detected_in_monovalent_and_bivalent/figuresGoogle Scholar ↗
  17. M. Gutschi, Quality issues with mRNA COVID vaccine production, (Nov. 02, 2022). Accessed: Nov. 02, 2022. [Online Video]. Available: https://www.bitchute.com/video/muB0nrznCAC4/Google Scholar ↗
  18. G. Pólya, “Über den zentralen Grenzwertsatz der Wahrscheinlichkeitsrechnung und das Momentenproblem [About the central limit theorem of the probability calculation and the moment problem],” Mathematische Zeitschrift, vol. 8, no. 3–4, pp. 171–181, 1920.Google Scholar ↗
  19. L. Le Cam, “The Central Limit Theorem around 1935,” Statistical Science, vol. 1, no. 1, pp. 78–91, 1986.Google Scholar ↗
  20. M. N. Mead, S. Seneff, J. Rose, R. Wolfinger, P. A. McCullough, and N. Hulscher, “COVID-19 modified mRNA ‘vaccines’: lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, part 2,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1275–1344, Aug. 2024, https://doi.org/10.56098/w66wjg87.DOI ↗Google Scholar ↗
  21. M. N. Mead et al., “COVID-19 modified mRNA ‘vaccines’: lessons learned from clinical trials, mass vaccination, and the bio-pharmaceutical complex, part 1,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1112–1178, Jun. 2024, https://doi.org/10.56098/fdrasy50.DOI ↗Google Scholar ↗
  22. J. W. Oller and D. Santiago, “All cause mortality and COVID-19 injections: evidence from 28 weeks of Public Health England ‘COVID-19 vaccine surveillance reports,’” International Journal of Vaccine Theory, Practice, and Research, vol. 2, no. 2, pp. 301–319, May 2022, https://doi.org/10.56098/ijvtpr.v2i2.42.DOI ↗Google Scholar ↗
  23. D. Santiago, “Playing Russian Roulette with every COVID-19 injection: the deadly global game,” International Journal of Vaccine Theory, Practice, and Research, vol. 2, no. 2, pp. 619–650, Oct. 2022, https://doi.org/10.56098/ijvtpr.v2i2.36.DOI ↗Google Scholar ↗
  24. D. Santiago, “A partial answer to the question posed by David A. Hughes, PhD, in the article: ‘What is in the so-called COVID-19 “vaccines”? Part 1: evidence of a global crime against humanity,’” International Journal of Vaccine Theory, Practice, and Research, vol. 2, no. 2, pp. 587–594, Sep. 2022, https://doi.org/10.56098/ijvtpr.v2i2.56.DOI ↗Google Scholar ↗
  25. Johns Hopkins Bloomberg School of Public Health, World Economic Forum, and Bill and Melinda Gates Foundation, “Event 201, a pandemic exercise to illustrate preparedness efforts.” Accessed: Dec. 09, 2021. [Online]. Available: https://centerforhealthsecurity.org/event201/Google Scholar ↗
  26. S. E. Peters et al., “Menstrual abnormalities strongly associated with proximity to COVID-19 vaccinated individuals,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1435–1461, Dec. 2024, https://doi.org/10.56098/tp99wn15.DOI ↗Google Scholar ↗
  27. K. A. Beattie, “Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries,” 2021, [Online]. Available: https://www.researchgate.net/publication/356248984_Worldwide_Bayesian_Causal_Impact_Analysis_of_Vaccine_Administration_on_Deaths_and_Cases_Associated_with_COVID-19_A_BigData_Analysis_of_145_CountriesGoogle Scholar ↗
  28. K. A. Beattie, Impacts on Death & Disease by COVID-19 Remedies. Dallas TX: International Journal of Vaccine Theory, Practice, and Research, 2024. [Online]. Available: TBAGoogle Scholar ↗
  29. D. Rancourt, “Nature of the COVID-era public health disaster in the USA from all-cause mortality and socio-geo-economic and climatic data.” Accessed: Sep. 07, 2022. [Online]. Available: https://vaccinesafety.info/2022/02/25/2021-10-25-nature-of-the-covid-era-public-health-disaster-in-the-usa-from-all-cause-mortality-and-socio-geo-economic-and-climatic-data-denis-rancourt-2/, https://denisrancourt.ca/entries.php?id=107&name=2021_10_25_nature_of_the_covid_era_public_health_disaster_in_the_usa_from_all_cause_mortality_and_socio_geo_economic_and_climatic_dataGoogle Scholar ↗
  30. D. Rancourt, M. Baudin, and J. Mercier, Staggering 17 million deaths after Covid jab rollouts, (Nov. 19, 2023). Accessed: Dec. 14, 2023. [Online Video]. Available: https://www.bitchute.com/video/jJg7E2ajQN2J/Google Scholar ↗
  31. J. J. Liu, C. M. Bell, J. J. Matelski, A. S. Detsky, and P. Cram, “Payments by US pharmaceutical and medical device manufacturers to US medical journal editors: retrospective observational study,” BMJ, vol. 359, p. j4619, Oct. 2017, https://doi.org/10.1136/bmj.j4619.DOI ↗Google Scholar ↗
  32. H. G. C. Van Spall and S. Whitelaw, “Medical publishing under review,” Eur. Heart J., vol. 42, no. 7, pp. 723–725, Feb. 2021, https://doi.org/10.1093/eurheartj/ehaa856.DOI ↗Google Scholar ↗
  33. T. Torgerson et al., “Ten Years Later: A Review of the US 2009 Institute of Medicine Report on Conflicts of Interest and Solutions for Further Reform,” BMJ Evid.-Based Med., vol. 27, no. 1, pp. 46–54, Feb. 2022, https://doi.org/10.1136/bmjebm-2020-111503.DOI ↗Google Scholar ↗
  34. J. A. Teixeira da Silva, J. Dobranszki, R. H. Bhar, and C. T. Mehlman, “Editors Should Declare Conflicts of Interest,” J. Bioethical Inq., vol. 16, no. 2, pp. 279–298, Jun. 2019, https://doi.org/10.1007/s11673-019-09908-2.DOI ↗Google Scholar ↗
  35. A. Makarem et al., “Conflict of interest in the peer review process: A survey of peer review reports,” PLoS One, vol. 18, no. 6, p. e0286908, Jun. 2023, https://doi.org/10.1371/journal.pone.0286908.DOI ↗Google Scholar ↗
  36. A. Lundh, K. Rasmussen, L. Ostengaard, I. Boutron, L. A. Stewart, and A. Hrobjartsson, “Systematic review finds that appraisal tools for medical research studies address conflicts of interest superficially,” J. Clin. Epidemiol., vol. 120, pp. 104–115, Apr. 2020, https://doi.org/10.1016/j.jclinepi.2019.12.005.DOI ↗Google Scholar ↗
  37. C. B. Korfitsen, C. H. Nejstgaard, A. Hrobjartsson, I. Boutron, L. Bero, and A. Lundh, “Peer reviewers’ conflicts of interest in biomedical research: scoping review,” BMJ Evid.-Based Med., vol. 30, no. 2, pp. 104–117, Apr. 2025, https://doi.org/10.1136/bmjebm-2024-112967.DOI ↗Google Scholar ↗
  38. C. M. Faggion, “Watching the watchers: A report on the disclosure of potential conflicts of interest by editors and editorial board members of dental journals,” Eur. J. Oral Sci., vol. 129, no. 6, Dec. 2021, https://doi.org/10.1111/eos.12823.DOI ↗Google Scholar ↗
  39. R. F. J. Kennedy, The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health. Skyhorse, 2021. [Online]. Available: https://www.amazon.com/s?k=the+real+anthony+fauci+robert+f+kennedy+jr+book&crid=5ZXMNU0B59VGoogle Scholar ↗
  40. C. Plank, O. Zelphati, and O. Mykhaylyk, “Magnetically enhanced nucleic acid delivery. Ten years of magnetofectionProgress and prospects,” Advanced Drug Delivery Reviews, vol. 63, no. 14, pp. 1300–1331, Nov. 2011, https://doi.org/10.1016/j.addr.2011.08.002.DOI ↗Google Scholar ↗
  41. C. C. Berry and A. S. G. Curtis, “Functionalisation of magnetic nanoparticles for applications in biomedicine,” J. Phys. D-Appl. Phys., vol. 36, no. 13, pp. R198–R206, Jul. 2003, https://doi.org/10.1088/0022-3727/36/13/203.DOI ↗Google Scholar ↗
  42. S. Qian et al., “Association analyses between urinary concentrations of multiple trace elements and gastric precancerous lesions and gastric cancer in Anhui province, eastern China,” Frontiers in Public Health, vol. 12, p. 1423286, 2024.Google Scholar ↗
  43. Y. Zhu et al., “Associated effects of blood metal(loid) exposure and impaired glucose metabolism in patients with gastric precancerous lesions or gastric cancer,” Biometals, vol. 38, no. 3, pp. 887–902, Jun. 2025, https://doi.org/10.1007/s10534-025-00684-8.DOI ↗Google Scholar ↗
  44. K. Widder, P. Marino, R. Morris, D. Howard, G. Poore, and A. Senyei, “Selective targeting of magnetic albumin microspheres to the Yoshida Sarcoma --- ultrastructural evaluation of microsphere disposition,” EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, vol. 19, no. 1, pp. 141-+, 1983, https://doi.org/10.1016/0277-5379(83)90409-1.DOI ↗Google Scholar ↗
  45. J. Larionova, Y. Guari, S. Sene, and G. Félix, “Chapter 331 - Luminescent lanthanide-based single-molecule magnets,” in Handbook on the Physics and Chemistry of Rare Earths, vol. 64, J.-C. G. Bunzli and S. M. Kauzlarich, Eds., in Handbook on the Physics and Chemistry of Rare Earths: Including Actinides, vol. 64. , Elsevier, 2023, pp. 93–173. https://doi.org/10.1016/bs.hpcre.2023.10.003.DOI ↗Google Scholar ↗
  46. M. Cruz-Acuna, J. R. Halman, K. A. Afonin, J. Dobson, and C. Rinaldi, “Magnetic nanoparticles loaded with functional RNA nanoparticles,” Nanoscale, vol. 10, no. 37, pp. 17761–17770, Oct. 2018, https://doi.org/10.1039/c8nr04254c.DOI ↗Google Scholar ↗
  47. K. D. Nance and J. L. Meier, “Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines,” ACS Cent Sci, vol. 7, no. 5, pp. 748–756, May 2021, https://doi.org/10.1021/acscentsci.1c00197.DOI ↗Google Scholar ↗
  48. D. Santiago, “A Closer Look at N1-methylpseudouridine in the Modified mRNA Injectables,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1345–1366, Oct. 2024, https://doi.org/10.56098/5azda593.DOI ↗Google Scholar ↗
  49. D. Lisse et al., “Engineered ferritin for magnetogenetic manipulation of proteins and organelles inside living cells,” Adv. Mater., vol. 29, no. 42, p. 1700189, Nov. 2017, https://doi.org/10.1002/adma.201700189.DOI ↗Google Scholar ↗
  50. M. Hernandez-Morales et al., “Electrophysiological mechanisms and validation of ferritin-based magnetogenetics for remote control of neurons,” J. Neurosci., vol. 44, no. 30, p. e1717232024, Jul. 2024, https://doi.org/10.1523/JNEUROSCI.1717-23.2024.DOI ↗Google Scholar ↗
  51. M. Hernandez-Morales, V. Han, R. H. Kramer, and C. Liu, “Evaluating methods and protocols of ferritin-based magnetogenetics,” iScience, vol. 24, no. 10, p. 103094, Oct. 2021, https://doi.org/10.1016/j.isci.2021.103094.DOI ↗Google Scholar ↗
  52. C. A. Shaw, Neural Dynamics of Neurological Disease. John Wiley & Sons, Inc., 2017. https://doi.org/10.1002/9781118634523.refs.DOI ↗Google Scholar ↗
  53. M. Babincova, S. Durdik, N. Babincova, P. Sourivong, and P. Babinec, “Application of cationized magnetoferritin for magnetic field-assisted delivery of short interfering RNA in vitro,” Lasers Med. Sci., vol. 33, no. 8, pp. 1807–1812, Nov. 2018, https://doi.org/10.1007/s10103-018-2547-0.DOI ↗Google Scholar ↗
  54. Y.-C. Chung, Y.-S. Chen, and S.-H. Lin, “Enhancement for gene transfection of low-descent-velocity bacteria using magnetic attraction in electroporation chip,” Sens. Actuator B-Chem., vol. 213, pp. 261–267, Jul. 2015, https://doi.org/10.1016/j.snb.2015.02.097.DOI ↗Google Scholar ↗
  55. C. Dahmani et al., “Rotational magnetic pulses enhance the magnetofection efficiency in vitro in adherent and suspension cells,” J. Magn. Magn. Mater., vol. 332, pp. 163–171, Apr. 2013, https://doi.org/10.1016/j.jmmm.2012.12.029.DOI ↗Google Scholar ↗
  56. E. Stride, C. Porter, A. G. Prieto, and Q. Pankhurst, “Enhancement of Microbubble Mediated Gene Delivery by Simultaneous Exposure to Ultrasonic and Magnetic Fields,” Ultrasound Med. Biol., vol. 35, no. 5, pp. 861–868, May 2009, https://doi.org/10.1016/j.ultrasmedbio.2008.11.010.DOI ↗Google Scholar ↗
  57. O. Mykhaylyk, Y. S. Antequera, D. Vlaskou, and C. Plank, “Generation of magnetic nonviral gene transfer agents and magnetofection in vitro,” Nat. Protoc., vol. 2, no. 10, pp. 2391–2411, 2007, https://doi.org/10.1038/nprot.2007.352.DOI ↗Google Scholar ↗
  58. S. Prijic et al., “Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field,” J. Membr. Biol., vol. 236, no. 1, pp. 167–179, Jul. 2010, https://doi.org/10.1007/s00232-010-9271-4.DOI ↗Google Scholar ↗
  59. Y.-K. Kim et al., “PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier,” Journal of Drug Targeting, vol. 24, no. 5, pp. 457–467, May 2016, https://doi.org/10.3109/1061186X.2015.1087527.DOI ↗Google Scholar ↗
  60. M. Uzhytchak et al., “The use of pulsed magnetic fields to increase the uptake of iron oxide nanoparticles by living cells,” Appl. Phys. Lett., vol. 111, no. 24, p. 243703, Dec. 2017, https://doi.org/10.1063/1.5007797.DOI ↗Google Scholar ↗
  61. S. D. Shirsat et al., “Endosomal escape in magnetic nanostructures: Recent advances and future perspectives,” Mater. Today Adv., vol. 22, p. 100484, Jun. 2024, https://doi.org/10.1016/j.mtadv.2024.100484.DOI ↗Google Scholar ↗
  62. Mito, “What are Mitochondria and Why They Matter - MitoCanada.” Accessed: May 02, 2025. [Online]. Available: https://mitocanada.org/what-are-mitochondria/Google Scholar ↗
  63. Kevin McKernan [@Kevin_McKernan], “Update https://t.co/E4NDjBF0F8,” Twitter. Accessed: Jun. 09, 2025. [Online]. Available: https://x.com/Kevin_McKernan/status/1931351886310834369Google Scholar ↗
  64. M. Playne, “URGENT WARNING - MRIs and VACCINE-INDUCED MAGNETISM,” Not On The Beeb. Accessed: May 14, 2025. [Online]. Available: https://www.notonthebeeb.co.uk/post/gp-urgent-warningGoogle Scholar ↗
  65. M. Playne and Not on the BEEB, “Vaccine Induced Magnetism,” Not on the Beeb. Accessed: Nov. 08, 2024. [Online]. Available: https://www.notonthebeeb.co.uk/magnetismGoogle Scholar ↗
  66. M. Playne and Not on the BEEB, “Magnetism Compilation,” Not On The Beeb. Accessed: Apr. 09, 2025. [Online]. Available: https://www.notonthebeeb.co.uk/magnet-challenge-compilationGoogle Scholar ↗
  67. D. Funke, “Fact check: COVID-19 vaccines aren’t magnetic,” USA TODAY. Accessed: Apr. 25, 2025. [Online]. Available: https://www.usatoday.com/story/news/factcheck/2021/06/21/fact-check-covid-19-vaccines-arent-magnetic/7698556002/Google Scholar ↗
  68. D. Broudy and V. Kyrie, “Syllogistic reasoning demystifies evidence of COVID-19 vaccine constituents,” International Journal of Vaccine Theory, Practice, and Research, vol. 2, no. 1, pp. 149–171, Dec. 2021, https://doi.org/10.56098/ijvtpr.v2i1.32.DOI ↗Google Scholar ↗
  69. P. McMillan, D. Kell, and Vejon Health, What If Clots Are the Missing Link?, (May 24, 2025). Accessed: May 27, 2025. [Online Video]. Available: https://www.youtube.com/watch?v=PdGmfxh-zdgGoogle Scholar ↗
  70. P. McMillan, Can Spike Protein Trigger a Mad Cow Disease Mimic?, (Apr. 24, 2025). Accessed: Apr. 25, 2025. [Online Video]. Available: https://www.youtube.com/watch?v=l8AsjEjgakkGoogle Scholar ↗
  71. Wolfram Research, Inc., “Magnetic Type for all the elements in the Periodic Table.” Accessed: Apr. 29, 2025. [Online]. Available: https://periodictable.com/Properties/A/MagneticType.v.htmlGoogle Scholar ↗
  72. Center for Nondestructive Evaluation, Iowa State University, “Nondestructive Evaluation Physics : Magnetism.” Accessed: Apr. 28, 2025. [Online]. Available: https://www.nde-ed.org/Physics/Magnetism/MagneticMatls.xhtmlGoogle Scholar ↗
  73. W. S. Bainbridge and M. C. Roco, Eds., Managing nano-bio-info-cogno innovations. Dordrecht: Springer Netherlands, 2006. https://doi.org/10.1007/1-4020-4107-1DOI ↗Google Scholar ↗
  74. S. Angerbauer, T. Pankratz, F. Enzenhofer, A. Springer, R. Khanzadeh, and W. Haselmayr, “Molecular nano neural networks (M3N): In-body intelligence for the IoBNT,” in ICC 2024-IEEE International Conference on Communications, IEEE, 2024, pp. 4819–4824. Accessed: Jun. 14, 2025. [Online]. Available: https://ieeexplore.ieee.org/abstract/document/10622358/Google Scholar ↗
  75. C. Lipps, “IoBNT - Internet of Bio-Nano-Things.” Accessed: Jun. 14, 2025. [Online]. Available: https://www.dfki.de/en/web/research/projects-and-publications/project/iobntGoogle Scholar ↗
  76. D. Santiago, “A Quantum Timing Change: Codon Energetics,” Mar. 11, 2025, Preprints: 2025030548. https://doi.org/10.20944/preprints202503.0548.v2.DOI ↗Google Scholar ↗
  77. R. P. Feynman, “The Feynman Lectures on Physics.” Accessed: Sep. 17, 2018. [Online]. Available: http://www.feynmanlectures.caltech.edu/I_01.htmlGoogle Scholar ↗
  78. U. Klein, “Quantizing Galilean spacetime: a reconstruction of Maxwell’s equations in empty space,” Quantum Stud. Math. Found., vol. 11, no. 3, pp. 717–737, Oct. 2024, https://doi.org/10.1007/s40509-024-00345-4.DOI ↗Google Scholar ↗
  79. H. Ueda, “The secret life of an electromagnon,” Lightsources.org. Accessed: Apr. 29, 2025. [Online]. Available: https://lightsources.org/2023/11/28/the-secret-life-of-an-electromagnon/Google Scholar ↗
  80. J. W. Oller, “The human language capacity and physics: eleven dimensions of empirical reality proved by construction,” Open Access Library Journal, vol. 10, no. 11, Art. no. 11, Nov. 2023, https://doi.org/10.4236/oalib.1110880.DOI ↗Google Scholar ↗
  81. R. Feynman, “The Feynman Lectures on Physics Vol. II Ch. 34: The Magnetism of Matter.” Accessed: Apr. 29, 2025. [Online]. Available: https://www.feynmanlectures.caltech.edu/II_34.htmlGoogle Scholar ↗
  82. Wikipedia, “Battelle Memorial Institute,” Wikipedia. Mar. 13, 2025. Accessed: May 02, 2025. [Online]. Available: https://en.wikipedia.org/w/index.php?title=Battelle_Memorial_Institute&oldid=1280216836Google Scholar ↗
  83. Battelle, “Battelle, IBM, Merck join UPMC’s effort to produce vaccines.” Accessed: Apr. 11, 2025. [Online]. Available: https://www.domain-b.com/industry/battelle-ibm-merck-join-upmc-s-effort-to-produce-vaccinesGoogle Scholar ↗
  84. “Battelle Neuro Team Advances to Phase II of DARPA N3 Program| Battelle Press Release,” Default. Accessed: Jan. 02, 2025. [Online]. Available: https://www.battelle.org/insights/newsroom/press-release-details/battelle-neuro-team-advances-to-phase-ii-of-darpa-n3-programGoogle Scholar ↗
  85. James Giordano, “DARPA’s N3: The Future of Non-Surgical Brain Interfaces,” Institute for Biodefense Research. Accessed: Jan. 02, 2025. [Online]. Available: https://biodefenseresearch.org/darpas-n3-the-future-of-non-surgical-brain-interfaces/Google Scholar ↗
  86. E. Staff, “Magnetism Plays Key Roles in DARPA Research to Develop Brain-Machine Interface without Surgery -.” Accessed: Jan. 02, 2025. [Online]. Available: https://magneticsmag.com/magnetism-plays-key-roles-in-darpa-research-to-develop-brain-machine-interface-without-surgery/Google Scholar ↗
  87. F. Deruelle, “The different sources of electromagnetic fields: Dangers are not limited to physical health,” Electromagnetic Biology and Medicine, vol. 39, no. 2, pp. 166–175, Apr. 2020, https://doi.org/10.1080/15368378.2020.1737811.DOI ↗Google Scholar ↗
  88. F. Deruelle, “The pharmaceutical industry is dangerous to health. Further proof with COVID-19,” Surg Neurol Int, vol. 13, p. 475, 2022, https://doi.org/10.25259/SNI_377_2022.DOI ↗Google Scholar ↗
  89. F. Deruelle, “Microwave radiofrequencies, 5G, 6G, graphene nanomaterials: Technologies used in neurological warfare,” Surgical Neurology International, vol. 15, no. 439, p. 1, 2024, https://doi.org/HTTPS://DOI.ORG/10.25259/SNI_731_2024.DOI ↗Google Scholar ↗
  90. H. Huelss, “Norms are what machines make of them: autonomous weapons systems and the normative implications of human-machine interactions,” Int. Polit. Sociol., vol. 14, no. 2, pp. 111–128, Jun. 2020, https://doi.org/10.1093/ips/olz023.DOI ↗Google Scholar ↗
  91. H. Huelss, “Transcending the fog of war? US military ‘AI’, vision, and the emergent post-scopic regime,” Eur. J. Int. Secur., May 2024, https://doi.org/10.1017/eis.2024.21.DOI ↗Google Scholar ↗
  92. D. A. Hughes, “COVID-19,” Psychological Operations, and the War for Technocracy: Volume 1. Cham: Springer International Publishing, 2024. https://doi.org/10.1007/978-3-031-41850-1.DOI ↗Google Scholar ↗
  93. P. M. Wood, D. A. Hughes, D. Broudy, L. Johnson, C. A. Fitts, and Technocracy News & Trends, OMNIWAR: Battle for the Brain Symposium, (Apr. 26, 2025). Accessed: May 02, 2025. [Online Video]. Available: https://www.youtube.com/watch?v=6A_medaFwV4Google Scholar ↗
  94. D. Hughes, V. Kyrie, and D. Broudy, “COVID-19 - Mass Formation or Mass Atrocity?,” Unlimited Hangout. Accessed: Jun. 15, 2025. [Online]. Available: https://unlimitedhangout.com/2022/11/investigative-reports/covid-19-mass-formation-or-mass-atrocity/Google Scholar ↗
  95. N. Hulscher, R. Hodkinson, W. Makis, and P. A. McCullough, “Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis,” ESC Heart Failure, vol. n/a, no. n/a, Jan. 2024, https://doi.org/10.1002/ehf2.14680.DOI ↗Google Scholar ↗
  96. S. Mansanguan, P. Charunwatthana, W. Piyaphanee, W. Dechkhajorn, A. Poolcharoen, and C. Mansanguan, “Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents,” Tropical Medicine and Infectious Disease, vol. 7, no. 8, Art. no. 8, Aug. 2022, https://doi.org/10.3390/tropicalmed7080196.DOI ↗Google Scholar ↗
  97. Y. R. Patel, D. W. Louis, M. Atalay, S. Agarwal, and N. R. Shah, “Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: a case series,” Journal of Cardiovascular Magnetic Resonance, vol. 23, no. 1, p. 101, Sep. 2021, https://doi.org/10.1186/s12968-021-00795-4.DOI ↗Google Scholar ↗
  98. C. L. F. Sun, E. Jaffe, and R. Levi, “Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave,” Sci Rep, vol. 12, no. 1, p. 6978, Apr. 2022, https://doi.org/10.1038/s41598-022-10928-z.DOI ↗Google Scholar ↗
  99. A. M. Kyriakopoulos, G. Nigh, P. A. McCullough, and S. Seneff, “Autoimmune and neoplastic outcomes after the mRNA vaccination: the role of T regulatory cell responses,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1395–1433, Oct. 2024, https://doi.org/10.56098/16j4nf05.DOI ↗Google Scholar ↗
  100. P. I. Parry et al., “‘Spikeopathy’: COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA,” Biomedicines, vol. 11, no. 8, Art. no. 8, Aug. 2023, https://doi.org/10.3390/biomedicines11082287.DOI ↗Google Scholar ↗
  101. A. M. Kyriakopoulos and S. Seneff, “Pathology Deterioration in a Pure β-zero Thalassemia Heterozygote After mRNA COVID-19 Vaccination: A Case Report and Literature Review,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 2, pp. 1245–1274, Aug. 2024, https://doi.org/10.56098/y768gc33.DOI ↗Google Scholar ↗
  102. J.-C. Pérez, C. Moret-Chalmin, and L. Montagnier, “Emergence of a new Creutzfeldt-Jakob disease: 26 cases of the human version of mad-cow disease, a few days after a COVID-19 injection,” International Journal of Vaccine Theory, Practice, and Research, vol. 3, no. 1, pp. 727–770, 2023, https://doi.org/https://doi.org/10.56098/ijvtpr.v3i1.66.DOI ↗Google Scholar ↗
  103. S. Pelech and C. A. Shaw, Down the COVID-19 Rabbit Hole. Skyhorse Publishing, 2024. [Online]. Available: https://www.amazon.com/Down-COVID-19-Rabbit-Hole-Independent/dp/1510779590Google Scholar ↗
  104. “Cancer rising in kids,” Mar. 26, 2025. [Online]. Available: https://x.com/tuckercarlson/status/1904941620283253060?s=12Google Scholar ↗
Author details
John W. Oller, Jr.
Professor Emeritus, Department of Linguistics, University of New Mexico, Albuquerque, NM, USA.
✉ Corresponding Author
ORCID ↗
👤 View Profile →
Daniel Santiago
Pharmacist, Independent Researcher, Orlando, Florida, USA.
ORCID ↗
👤 View Profile →
Daniel Broudy
Professor of Applied Linguistics, Okinawa Christian University, Nishihara-cho, Okinawa 903-0207, Japan.
ORCID ↗
👤 View Profile →🔗 Is this you? Claim this publication